EE340 Integrating Real-World Evidence in Economic Evaluation of Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation in a Developing Country

American journal of cardiovascular drugs : drugs, devices, and other interventions(2023)

引用 0|浏览14
暂无评分
摘要
In a developing country where suboptimal anticoagulation control is common, apixaban was the cost-effective alternative to warfarin for patients with both low and intermediate TTR control.
更多
查看译文
关键词
oral anticoagulants,stroke prevention,atrial fibrillation,economic evaluation,real-world,non-valvular
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要